C.R. Bard gets FDA warning letter over Puerto Rico plant

10/14/2008 | AlertNet

The FDA has issued a warning letter to C.R. Bard urging the company to fix manufacturing violations found at its plant in Puerto Rico during agency inspections from November through February. Products made at the facility include the Vacora Biopsy Probe and the Kugel Hernia Patch. The company said it "intends to fully implement corrective actions to address the concerns identified."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC